Minerva Historical Income Statement

NERV Stock

USD 2.26 0.00 0.00%

Historical analysis of Minerva Neurosciences income statement accounts such as Other Operating Expenses of 38.3 M can show how well Minerva Neurosciences performed in making a profits. Evaluating Minerva Neurosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Minerva Neurosciences's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Minerva Neurosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Minerva Neurosciences is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.

About Minerva Income Statement Analysis

Minerva Neurosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Minerva Neurosciences shareholders. The income statement also shows Minerva investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Minerva Neurosciences Income Statement Chart

At this time, Minerva Neurosciences' Interest Expense is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 10.9 B in 2024, whereas Operating Income is likely to drop (24.3 M) in 2024.

Selling General Administrative Other Operating Expenses Research Development Net Income

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Minerva Neurosciences. It is also known as Minerva Neurosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Minerva Neurosciences financial statement analysis. It represents the amount of money remaining after all of Minerva Neurosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most accounts from Minerva Neurosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Minerva Neurosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.At this time, Minerva Neurosciences' Interest Expense is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 10.9 B in 2024, whereas Operating Income is likely to drop (24.3 M) in 2024.

	2023	2024 (projected)
Extraordinary Items	8.5M	7.5M
Reconciled Depreciation	29.6K	57.8K

Extraordinary Items Reconciled Depreciation

Minerva Neurosciences income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Income From Continuing Ops	Non Operating Income Net Other	Interest Income	Net Interest Income	Tax Provision	Reconciled Depreciation	Extraordinary Items	Selling And Marketing Expenses
Depreciation And Amortization		-0.11	-0.15	0.76	-0.5	-0.51	0.72	-0.51	0.76	-0.46	0.23	-0.44	-0.2	0.12	0.68	-0.04	0.25	0.59	0.79	0.14	0.14
Interest Expense	-0.11		0.73	0.17	-0.18	-0.18	0.02	-0.18	0.17	-0.31	-0.96	-0.36	0.25	0.24	-0.22	-0.17	-0.97	0.63	0.07	-0.7	-0.7
Selling General Administrative	-0.15	0.73		0.01	0.05	0.08	-0.18	0.08	0.01	-0.03	-0.65	-0.04	0.01	0.3	-0.16	0.18	-0.7	0.47	0.01	-0.95	-0.95
Other Operating Expenses	0.76	0.17	0.01		-0.89	-0.88	0.97	-0.88	1.0	-0.88	0.05	-0.86	-0.18	0.01	0.64	0.07	0.04	0.47	0.56	-0.05	-0.05
Operating Income	-0.5	-0.18	0.05	-0.89		1.0	-0.92	1.0	-0.89	0.99	-0.06	0.97	0.17	0.31	-0.68	-0.32	-0.01	-0.25	-0.23	-0.05	-0.05
Ebit	-0.51	-0.18	0.08	-0.88	1.0		-0.92	1.0	-0.88	0.99	-0.05	0.97	0.18	0.32	-0.66	-0.28	0.0	-0.25	-0.24	-0.08	-0.08
Research Development	0.72	0.02	-0.18	0.97	-0.92	-0.92		-0.92	0.97	-0.89	0.2	-0.87	-0.22	-0.14	0.66	0.13	0.18	0.29	0.49	0.17	0.17
Ebitda	-0.51	-0.18	0.08	-0.88	1.0	1.0	-0.92		-0.88	0.99	-0.04	0.97	0.18	0.32	-0.66	-0.28	0.0	-0.25	-0.24	-0.08	-0.08
Total Operating Expenses	0.76	0.17	0.01	1.0	-0.89	-0.88	0.97	-0.88		-0.88	0.05	-0.86	-0.18	0.01	0.64	0.07	0.04	0.46	0.56	-0.04	-0.04
Income Before Tax	-0.46	-0.31	-0.03	-0.88	0.99	0.99	-0.89	0.99	-0.88		0.08	0.99	0.13	0.27	-0.61	-0.27	0.13	-0.31	-0.22	0.04	0.04
Total Other Income Expense Net	0.23	-0.96	-0.65	0.05	-0.06	-0.05	0.2	-0.04	0.05	0.08		0.13	-0.3	-0.28	0.41	0.34	0.99	-0.57	-0.02	0.6	0.6
Net Income	-0.44	-0.36	-0.04	-0.86	0.97	0.97	-0.87	0.97	-0.86	0.99	0.13		0.0	0.27	-0.57	-0.26	0.18	-0.36	-0.21	0.04	0.04
Income Tax Expense	-0.2	0.25	0.01	-0.18	0.17	0.18	-0.22	0.18	-0.18	0.13	-0.3	0.0		0.03	-0.31	-0.04	-0.28	0.25	-0.19	-0.01	-0.01
Net Income From Continuing Ops	0.12	0.24	0.3	0.01	0.31	0.32	-0.14	0.32	0.01	0.27	-0.28	0.27	0.03		-0.26	-0.46	-0.25	0.35	0.19	-0.27	-0.27
Non Operating Income Net Other	0.68	-0.22	-0.16	0.64	-0.68	-0.66	0.66	-0.66	0.64	-0.61	0.41	-0.57	-0.31	-0.26		0.55	0.34	0.3	0.24	0.15	0.15
Interest Income	-0.04	-0.17	0.18	0.07	-0.32	-0.28	0.13	-0.28	0.07	-0.27	0.34	-0.26	-0.04	-0.46	0.55		0.22	-0.12	-0.38	-0.09	-0.09
Net Interest Income	0.25	-0.97	-0.7	0.04	-0.01	0.0	0.18	0.0	0.04	0.13	0.99	0.18	-0.28	-0.25	0.34	0.22		-0.57	0.05	0.65	0.65
Tax Provision	0.59	0.63	0.47	0.47	-0.25	-0.25	0.29	-0.25	0.46	-0.31	-0.57	-0.36	0.25	0.35	0.3	-0.12	-0.57		0.55	-0.44	-0.44
Reconciled Depreciation	0.79	0.07	0.01	0.56	-0.23	-0.24	0.49	-0.24	0.56	-0.22	-0.02	-0.21	-0.19	0.19	0.24	-0.38	0.05	0.55		-0.04	-0.04
Extraordinary Items	0.14	-0.7	-0.95	-0.05	-0.05	-0.08	0.17	-0.08	-0.04	0.04	0.6	0.04	-0.01	-0.27	0.15	-0.09	0.65	-0.44	-0.04		1.0
Selling And Marketing Expenses	0.14	-0.7	-0.95	-0.05	-0.05	-0.08	0.17	-0.08	-0.04	0.04	0.6	0.04	-0.01	-0.27	0.15	-0.09	0.65	-0.44	-0.04	1.0

Click cells to compare fundamentals

Minerva Neurosciences Account Relationship Matchups

Minerva Neurosciences income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	171.9K	176.2K	101.8K	8.5K	31.0K	29.4K
Selling General Administrative	17.7M	17.3M	13.3M	10.6M	10.4B	10.9B
Other Operating Expenses	75.9M	39.3M	45.4M	25.2M	23.1M	38.3M
Operating Income	(75.9M)	1.8M	(45.4M)	(25.2M)	(23.1M)	(24.3M)
Ebit	(76.0M)	1.8M	(51.7M)	(24.7M)	(21.7M)	(22.8M)
Research Development	58.1M	22.0M	32.0M	14.6M	12.7M	12.1M
Ebitda	(75.9M)	1.9M	(51.6M)	(24.7M)	(21.7M)	(22.8M)
Total Operating Expenses	75.9M	39.3M	45.4M	25.2M	23.1M	38.3M
Income Before Tax	(74.4M)	1.9M	(51.7M)	(32.1M)	(30.0M)	(31.5M)
Total Other Income Expense Net	1.4M	94.0K	(6.3M)	(6.9M)	(6.9M)	(6.5M)
Net Income	(72.2M)	1.9M	(49.9M)	(39.0M)	(30.0M)	(31.5M)
Income Tax Expense	(2.3M)	(94.0K)	(1.8M)	6.9M	(2.0)	(2.1)
Gross Profit	(161.5K)	41.2M	(101.8K)	(8.5K)	(31.0K)	(29.4K)
Net Income From Continuing Ops	(72.2M)	1.9M	(49.9M)	(32.1M)	(27.7M)	(29.1M)
Non Operating Income Net Other	884.9K	1.7M	1.4M	94.0K	108.1K	102.7K
Net Income Applicable To Common Shares	(72.2M)	1.9M	(49.9M)	(32.1M)	(36.9M)	(38.8M)
Interest Income	1.7M	1.4M	16.5K	556.9K	1.4M	788.1K
Reconciled Depreciation	161.5K	176.2K	101.8K	8.5K	29.6K	57.8K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Minerva Stock Analysis

When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Minerva Historical Income Statement

About Minerva Income Statement Analysis

Minerva Neurosciences Income Statement Chart

Other Operating Expenses

Net Income

Minerva Neurosciences income statement Correlations

Minerva Neurosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Minerva Neurosciences income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Minerva Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Selling And Marketing Expenses	+ 1.0	Extraordinary Items
Income Before Tax	+ 0.99	Operating Income

Net Interest Income	- 0.97	Interest Expense
Total Other Income Expense Net	- 0.96	Interest Expense
Selling And Marketing Expenses	- 0.95	Selling General Administrative
Extraordinary Items	- 0.95	Selling General Administrative
Ebitda	- 0.92	Research Development
Research Development	- 0.92	Ebit